Presurgical Cytoreduction of Oral Cancer Using Intra-arterial Cisplatin and Limited Concomitant Radiation Therapy (Neo-RADPLAT)

Archives of Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 1, 2004, Pages 28-32

  Robbins, K Thomas ^a,b   Samant, Sandeep ^a   Vieira, Francisco ^a   Kumar, Parvesh ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; SODIUM THIOSULFATE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN TISSUE; MALE; MOUTH CANCER; MOUTH CAVITY; MUCOSA INFLAMMATION; NEUROTOXICITY; PREOPERATIVE TREATMENT; PROSPECTIVE STUDY; RADIATION DOSE; SOFT PALATE; TONGUE; TONSIL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; THIOSULFATES; TREATMENT OUTCOME;

EID: 0347004537     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.130.1.28     Document Type: Article

References (12)

1. Samant S, Robbins KT, Wong FSH, Kumar P. Concomitant intra-arterial (IA) cisplatin, abbreviated radiotherapy and limited surgery for intermediate oral and oropharyngeal cancers. In: Proceedings of the Fifth International Conference on Head and Neck Cancer. Madison, Wis: Omnipress; 2000:140. Abstract 295.
2. Kerber CW, Wong WH, Howell SB, Hanchett C, Robbins KT. An organ-preserving selective arterial chemotherapy strategy for head and neck cancer. AJNR Am J Neuroradiol. 1998;19:935-941.
3. Robbins KT, Storniolo AM, Kerber C, et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol. 1994;12:2113-2120.
4. Schuller DE, Wilson HE, Smith RE, et al. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope. 1988;98:1205-1211.
5. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685-1690.
6. Lefebvre J-L, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst. 1996;88:890-899.
7. Wanebo HJ, Chouguie P, Akerley WL III, et al. Pre-operative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer. Am J Surg. 1997;174:518-522.
8. Wanebo HJ, Glicksman AS, Landman C, et al. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer. Am J Surg. 1995;170:512-516.
9. Slotman GJ, Doolittle CH, Glicksman AS. Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer: five-year results with impressive complete response rates and high survival. Cancer. 1992;69:2736-2743.
10. Robbins KT, Kumar P, Wong FSH, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck. 2000;22:687-693.
11. Begg AC, van der Kolk PJ, Dewit L, Bartelink H. Radiosensitization by cisplatin of RIF1 tumour cells in vitro. Int J Radiat Biol Relat Stud Phys Chem Med. 1986;50:871-884.
12. Bartelink H, Kallman RF, Rapacchietta D, Hart GA. Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation. Radiother Oncol. 1986;6:61-74.